Expanded Access Programs 2019
March 27 - 28, 2019 - Philadelphia MA US

CBI a division of UBM Americas

Phone: 3392982131

Linking Pre-Approval Access with Drug Development Strategy CBI’s Expanded Access Programs 2019 focuses on the design, development and practical implementation of early access programs. The summit convenes top industry stakeholders and regulators to examine current approaches in providing investigational, pre-launch or end-of-lifecycle drugs to patients for treatment purposes. A multi-stakeholder faculty will address key issues affecting EAPs and review the potential impact of the shifting legislative landscape.

More Information